Clinical Trial Update: Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of pregabalin (Lyrica) and lofexidine (Lucemyra) for opioid withdrawal; results were posted after completion in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid Withdrawal

Drugs mentioned

• LUCEMYRA (LOFEXIDINE HYDROCHLORIDE)
• Lyrica (Pregabalin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Opioid Withdrawal | Phase 2 | Status: COMPLETED | Results posted: 2024-05-20